Granite Investment Partners, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1542266 EL SEGUNDO, CA

Position in LGND

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$10,812,045

-$140,023 QoQ

Shares Held

54,155

-6.5% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.70%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Granite Investment Partners, LLC holds $55,186,477 across 10 Biotechnology names. LGND ranks #2 (19.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	80,299	$13,572,136
2	LGND	Ligand Pharmaceuticals Inc This page	54,155	$10,812,045
3	APLS	Apellis Pharmaceuticals, Inc.	231,917	$9,330,020
4	TECH	BIO-TECHNE Corp	137,562	$7,188,990
5	KRYS	Krystal Biotech, Inc.	24,284	$6,273,042
6	VCEL	Vericel Corp	120,236	$3,867,992
7	HALO	Halozyme Therapeutics, Inc.	51,719	$3,342,598
8	IONS	Ionis Pharmaceuticals Inc	5,345	$401,356

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,812,045	54,155	-6.5%	Shares	Sole	2026-04-30
2025-12-31	$10,952,068	57,926	-6.0%	Shares	Sole	2026-02-12
2025-09-30	$10,915,366	61,620	-50.5%	Shares	Sole	2025-11-10
2025-06-30	$14,148,840	124,462	-6.5%	Shares	Sole	2025-08-13
2025-03-31	$13,997,183	133,129	+15.2%	Shares	Sole	2025-05-13
2024-12-31	$12,379,896	115,538	-2.1%	Shares	Sole	2025-02-13
2024-09-30	$11,810,720	118,001	+219.7%	Shares	Sole	2024-11-12
2020-12-31	$2,290,140	36,914	-62.0%	Shares	Sole	2021-02-12
2020-09-30	$5,777,592	97,162	-51.5%	Shares	Sole	2020-11-06
2020-06-30	$13,983,408	200,406	+468.7%	Shares	Sole	2020-08-03
2020-03-31	$1,598,522	35,237	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.